Arcus Biosciences, Inc. (RCUS) Social Stream



Arcus Biosciences, Inc. (RCUS): $35.71

1.25 (+3.63%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add RCUS to Watchlist
Sign Up

Industry: Biotech


Ranked

of 381

in industry

ARCUS BIOSCIENCES INC (RCUS) Price Targets From Analysts

Use the tables below to see what analysts covering ARCUS BIOSCIENCES INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-09 8 $70 $50 $59.833 $35.17 70.13%
2021-11-17 8 $70 $48 $58.142 $35.17 65.32%
2021-11-18 8 $100 $48 $62.714 $35.17 78.32%
2021-11-22 9 $100 $48 $64.857 $35.17 84.41%
2022-02-24 7 $100.001 $53 $67 $35.17 90.5%
2022-04-12 7 $100.001 $53 $68 $35.17 93.35%
2022-05-10 7 $77 $53 $63.143 $35.17 79.54%
2022-05-13 7 $77 $42 $59.571 $35.17 69.38%
2022-07-08 7 $66 $42 $55.714 $35.17 58.41%
2022-08-04 7 $60 $36 $50.428 $35.17 43.38%
2022-08-18 7 $60 $36 $48.571 $35.17 38.1%
2022-08-31 8 $60 $36 $48.875 $35.17 38.97%
2022-10-11 9 $60 $36 $47.875 $35.17 36.12%
2022-10-14 8 $60 $36 $45.285 $35.17 28.76%
2022-11-03 7 $60 $36 $45.125 $35.17 28.31%
2022-11-18 7 $51 $33 $41.75 $35.17 18.71%
2022-11-23 8 $51 $33 $41.375 $35.17 17.64%

The Trend in the Analyst Price Target


Over the past 138 days, RCUS's average price target has gone down $14.34.

Over the past 45 weeks, RCUS's average upside potential has been 103.94%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-04-01 7 100.001 53 68.000 31.99 112.57%
2022-04-12 7 100.001 53 68.000 30.75 121.14%
2022-10-14 8 60.000 36 45.285 26.64 69.99%
2022-11-03 8 60.000 36 45.125 24.37 85.17%
2022-11-18 8 51.000 33 41.750 27.31 52.87%

RCUS Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.31 6 1 1 0 0 8

The Trend in the Broker Recommendations


Over the past 43 weeks, RCUS's average broker recommendation rating worsened by 0.38.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for RCUS as an investment opportunity.

  • In terms of how ARCUS BIOSCIENCES INC fares relative to Pharmaceutical Products stocks, note that its upside potential (average analyst target price relative to current price) is higher than 716.62% of that group.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, ARCUS BIOSCIENCES INC's average analyst price target is higher than 1960.1% of them.
  • RCUS has a lower variance in analysts' estimates than -962.02% of Pharmaceutical Products stocks.
  • In terms of how ARCUS BIOSCIENCES INC fares relative to Pharmaceutical Products stocks, note that its number of analysts covering the stock is higher than 1690.75% of that group.

In the Pharmaceutical Products industry, HCM, MYOV, and ORGO are the three stocks most similar to ARCUS BIOSCIENCES INC regarding the price target and analyst recommendation information presented here.

What is the outlook for RCUS? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.7037 seconds.